NEW

FDA, Cardinal Health Assess Scope of Potential Contamination Risk

Dr. Jeffrey E. Shuren MD, JD, Director - CDRH Offices: Office of the Center Director, released the following statement on Thursday (January 16, 2020): “On Jan. 11 and again on Jan. 15, 2020, medical device manufacturer Cardinal Health alerted its customers to...

U.S Health System Uses Medtronic Stealth Autoguide Cranial Robotic Guidance Platform

Phoenix Children’s Hospital is the first-ever health system in the U.S. to receive and deploy the newly FDA-cleared Medtronic Stealth Autoguide platform.

Cook Medical TriForce Peripheral Crossing Set Now Available

Cook Medical’s TriForce® Peripheral Crossing Set is now commercially available. As of January 2020, these products are available to physicians in the United States to support procedures to treat patients with vascular obstructions.

PENTAX Medical Launches IMAGINA Endoscopy System in U.S.

IMAGINA offers practitioners a modern user interface and unique endoscope design to provide excellent visualization, improve the operator experience and positively influence long-term patient care costs.

TransEnterix Announces Ochsner Health System to Initiate Program with the Senhance Surgical System

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)– TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Ochsner Health System has entered into an agreement to lease and utilize a Senhance® System that has been installed at the Ochsner Baptist* facility. This placement is one of the two placements referenced in the Company’s January 6, 2020 press release.

The Senhance System is the first new abdominal robotic surgery platform to receive FDA clearance since 2000. It is the first and only digital laparoscopic surgical platform designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation including, 3 mm microlaparoscopic instruments, eye sensing camera control and reusable standard instruments to help maintain per-procedure costs similar to traditional laparoscopy.

“We are pleased that Ochsner Baptist Medical Center is beginning its digital laparoscopy program using the Senhance Surgical System,” said Anthony Fernando, president and chief executive officer at TransEnterix. “Our system is designed to minimize invasiveness, maximize control, and support responsible economics for the hospital. We look forward to partnering with the surgeons at Ochsner Baptist to advance patient care in ways that matter in today’s value-based healthcare landscape.”

“I’m excited to bring new minimally invasive technology to the patients at Ochsner Baptist,” said Dr. George B. Morris, IV, chairman of OB/GYN at Ochsner Baptist. “We believe new technology, such as the Senhance Surgical System, will allow our skilled surgeons to maximize control, offer precise surgery, and minimize invasiveness for patients.”

“As a health system, we are continuing to drive innovation as part of our mission to serve our patients,“ said Beth Walker, chief executive officer Ochsner Baptist. “We evaluated the Senhance Surgical System and believe it will be a welcome addition to our leading offering for patients seeking advanced minimally invasive and robotic surgery.”

*Ochsner Baptist – a campus of Ochsner Medical Center

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X